Quick Takeaways
- This page summarizes Brian O'Callaghan's Form 3 filing for Indaptus Therapeutics, Inc. (INDP).
- 0 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 06 Aug 2021, 16:35.
Brian O'Callaghan - 03 Aug 2021 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Role
- Director
- Signature
- /s/ Diana Douglas, as Attorney-in-Fact for Brian O'Callaghan
- Issuer symbol
- INDP
- Transactions as of
- 03 Aug 2021
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 06 Aug 2021, 16:35:52 UTC
- Next filing
- 06 Aug 2021
- SEC
- View on sec.gov
Quoteable Key Fact
"Brian O'Callaghan filed Form 3 for Indaptus Therapeutics, Inc. (INDP) on 06 Aug 2021."
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | INDP | Stock Option (right to buy) | 03 Aug 2021 | Common Stock | 20,926 | $2.80 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Options to buy 19,190 shares are fully vested and exercisable. The remaining options shall vest at the rate of an additional 582 shares on the first calendar day of each month commencing September 1, 2021, such that all Options shall be fully vested on November 1, 2021. |